Dermapharm Holding SE (LON:0A5J)

Market Cap	1.75B
Revenue (ttm)	976.88M
Net Income (ttm)	75.38M
Shares Out	n/a
EPS (ttm)	1.40
PE Ratio	23.24
Forward PE	n/a
Dividend	0.75 (1.94%)
Ex-Dividend Date	Jun 28, 2024

Volume	897
Average Volume	23,578
Open	38.73
Previous Close	38.92
Day's Range	38.80 - 39.35
52-Week Range	24.97 - 35.50
Beta	n/a
RSI	51.17
Earnings Date	Mar 14, 2025

About Dermapharm Holding SE

Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany. The company operates through three segments: Branded Pharmaceuticals and Other Healthcare Products, Parallel Import Business, and Herbal Extracts. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company also provides vitamins, minerals, food supplements, as well as products for dermatology, allergology, pain a...

• Industry: Pharmaceutical Preparations
• Founded: 1991
• Employees: 3,497
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0A5J

Financial Performance

In 2023, Dermapharm Holding SE's revenue was 1.15 billion, an increase of 10.59% compared to the previous year's 1.04 billion. Earnings were 62.37 million, a decrease of -53.54%.

Financial numbers in EUR